etravirine has been researched along with Diathesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Mendoza, C; González, Mdel M; Pattery, T; Poveda, E; Soriano, V; Villacian, J | 1 |
| Azijn, H; de Béthune, MP; De Smedt, G; Hoogstoel, A; Nijs, S; Peeters, M; Picchio, G; Tambuyzer, L; Vingerhoets, J; Woodfall, B | 1 |
2 other study(ies) available for etravirine and Diathesis
| Article | Year |
|---|---|
Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues.
Topics: Anti-HIV Agents; Disease Susceptibility; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Nitriles; Phenotype; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Treatment Failure | 2008 |
Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies.
Topics: Anti-HIV Agents; Clinical Trials, Phase III as Topic; Disease Susceptibility; Drug Resistance, Viral; Genotype; HIV Infections; HIV-1; Humans; Mutation; Nitriles; Phenotype; Pyridazines; Pyrimidines; Randomized Controlled Trials as Topic; Treatment Outcome; Viral Load | 2010 |